Literature DB >> 26676664

Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis.

Konstantinos Tziomalos1, Vasilios G Athyros2.   

Abstract

Diabetic nephropathy is the leading cause of end-stage renal disease. Patients with diabetic nephropathy have a high cardiovascular risk, comparable to patients with coronary heart disease. Accordingly, identification and management of risk factors for diabetic nephropathy as well as timely diagnosis and prompt management of the condition are of paramount importance for effective treatment. A variety of risk factors promotes the development and progression of diabetic nephropathy, including elevated glucose levels, long duration of diabetes, high blood pressure, obesity, and dyslipidemia. Most of these risk factors are modifiable by antidiabetic, antihypertensive, or lipid-lowering treatment and lifestyle changes. Others such as genetic factors or advanced age cannot be modified. Therefore, the rigorous management of the modifiable risk factors is essential for preventing and delaying the decline in renal function. Early diagnosis of diabetic nephropathy is another essential component in the management of diabetes and its complications such as nephropathy. New markers may allow earlier diagnosis of this common and serious complication, but further studies are needed to clarify their additive predictive value, and to define their cost-benefit ratio. This article reviews the most important risk factors in the development and progression of diabetic nephropathy and summarizes recent developments in the diagnosis of this disease.

Entities:  

Mesh:

Year:  2015        PMID: 26676664      PMCID: PMC5397986          DOI: 10.1900/RDS.2015.12.110

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN: 1613-6071


  87 in total

1.  Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.

Authors:  Monika A Niewczas; Tomohito Gohda; Jan Skupien; Adam M Smiles; William H Walker; Florencia Rosetti; Xavier Cullere; John H Eckfeldt; Alessandro Doria; Tanya N Mayadas; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 10.121

2.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.

Authors:  E R Seaquist; F C Goetz; S Rich; J Barbosa
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

3.  Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.

Authors:  T Kazumi; T Hozumi; Y Ishida; Y Ikeda; K Kishi; M Hayakawa; G Yoshino
Journal:  Diabetes Care       Date:  1999-07       Impact factor: 19.112

4.  Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.

Authors:  Vishal S Vaidya; Monika A Niewczas; Linda H Ficociello; Amanda C Johnson; Fitz B Collings; James H Warram; Andrzej S Krolewski; Joseph V Bonventre
Journal:  Kidney Int       Date:  2010-10-27       Impact factor: 10.612

5.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

Authors:  H H Parving; H Lehnert; J Bröchner-Mortensen; R Gomis; S Andersen; P Arner
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

6.  Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT).

Authors:  Elizabeth F O Kern; Penny Erhard; Wanjie Sun; Saul Genuth; Miriam F Weiss
Journal:  Am J Kidney Dis       Date:  2010-05       Impact factor: 8.860

7.  In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.

Authors:  Bruce A Perkins; Linda H Ficociello; Bijan Roshan; James H Warram; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2010-01       Impact factor: 10.612

8.  Predicting diabetic nephropathy in insulin-dependent patients.

Authors:  C E Mogensen; C K Christensen
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

9.  Nonalbuminuric renal insufficiency in type 2 diabetes.

Authors:  Richard J MacIsaac; Con Tsalamandris; Sianna Panagiotopoulos; Trudy J Smith; Karen J McNeil; George Jerums
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

10.  A genome-wide search for linkage of estimated glomerular filtration rate (eGFR) in the Family Investigation of Nephropathy and Diabetes (FIND).

Authors:  Farook Thameem; Robert P Igo; Barry I Freedman; Carl Langefeld; Robert L Hanson; Jeffrey R Schelling; Robert C Elston; Ravindranath Duggirala; Susanne B Nicholas; Katrina A B Goddard; Jasmin Divers; Xiuqing Guo; Eli Ipp; Paul L Kimmel; Lucy A Meoni; Vallabh O Shah; Michael W Smith; Cheryl A Winkler; Philip G Zager; William C Knowler; Robert G Nelson; Madeline V Pahl; Rulan S Parekh; W H Linda Kao; Rebekah S Rasooly; Sharon G Adler; Hanna E Abboud; Sudha K Iyengar; John R Sedor
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

View more
  56 in total

1.  ANGPTL2 regulates autophagy through the MEK/ERK/Nrf-1 pathway and affects the progression of renal fibrosis in diabetic nephropathy.

Authors:  Haiquan Huang; Haifeng Ni; Kunling Ma; Jihong Zou
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

2.  Neuregulin 4 attenuate tubulointerstitial fibrosis and advanced glycosylation end products accumulation in diabetic nephropathy rats via regulating TNF-R1 signaling.

Authors:  Jinbao Shi; Weilong Xu; Ruiping Zheng; Huizi Miao; Qiaosheng Hu
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

3.  U.S. county "food swamp" severity and hospitalization rates among adults with diabetes: A nonlinear relationship.

Authors:  Aryn Z Phillips; Hector P Rodriguez
Journal:  Soc Sci Med       Date:  2020-02-15       Impact factor: 4.634

4.  SMAD3 promotes autophagy dysregulation by triggering lysosome depletion in tubular epithelial cells in diabetic nephropathy.

Authors:  Chen Yang; Xiao-Cui Chen; Zhi-Hang Li; Hong-Luan Wu; Kai-Peng Jing; Xiao-Ru Huang; Lin Ye; Biao Wei; Hui-Yao Lan; Hua-Feng Liu
Journal:  Autophagy       Date:  2020-10-12       Impact factor: 16.016

5.  Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway.

Authors:  Yi Zeng; Zhijian Feng; Yunjuan Liao; Ming Yang; Yihua Bai; Zhenkun He
Journal:  Cell Cycle       Date:  2020-12-14       Impact factor: 4.534

6.  Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease.

Authors:  Federica Piani; Trenton Reinicke; Yuliya Lytvyn; Isabella Melena; Leif E Lovblom; Vesta Lai; Josephine Tse; Leslie Cham; Andrej Orszag; Bruce A Perkins; David Z I Cherney; Petter Bjornstad
Journal:  J Diabetes Complications       Date:  2020-11-26       Impact factor: 2.852

7.  Association between changes in the mRNA expression of platelet-activating factor receptor in peripheral blood mononuclear cells and progression of diabetic nephropathy.

Authors:  Sahar Ghavidel Darestani; Mihoko Kurano; Atsushi Shinnakasu; Kiyoaki Yamamoto; Yukari Dochi; Kayo Uemura; Yuko Ikeda; Aiko Arimura; Hiroshi Arimura; Akira Kikuchi; Hiroshi Hashiguchi; Takahisa Deguchi; Yoshihiko Nishio
Journal:  Diabetol Int       Date:  2019-04-11

8.  Emodin Attenuated the Kidney Damage of High-Fat-Diet Mice via the Upregulation of Glucagon-Like Peptide-1 Receptor.

Authors:  Jinlei Liu; Yao Sun; Hongwei Zheng; Jing Wang; Lili Liu; Bing Song; Haoqiang Zhang
Journal:  Biomed Res Int       Date:  2021-05-31       Impact factor: 3.411

Review 9.  Flavonoids on diabetic nephropathy: advances and therapeutic opportunities.

Authors:  Qichao Hu; Caiyan Qu; Xiaolin Xiao; Wenwen Zhang; Yinxiao Jiang; Zhao Wu; Dan Song; Xi Peng; Xiao Ma; YanLing Zhao
Journal:  Chin Med       Date:  2021-08-07       Impact factor: 5.455

10.  Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome‑mediated inflammation.

Authors:  Hui Feng; Xiaoyun Zhu; Yang Tang; Shouqiang Fu; Bingtan Kong; Ximing Liu
Journal:  Int J Mol Med       Date:  2021-07-19       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.